Dong-A St
KOSE:A170900
South Korea / Healthcare / Pharmaceuticals
Exchange Data
Hide this widget
Price
43,600.00 KRW
Day change
0.00 (0.00%)
52-week range
42,700.00 - 80,700
5:29 pm - Closed
Summary of Dong-A St
Hide this widget
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, i...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
- (-)
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| A170900 | Peers | Sector | |
|---|---|---|---|
Market Cap | 399.5 B | 188.2 B | 93.382 B |
Price % of 52 Week High | Premium | 66.1% | 61.6% |
Dividend Yield | 1.6% | 2.0% | 0.0% |
Shareholder Yield | Premium | -7.4% | -0.7% |
1 Year Price Total Return | -36.1% | -20.6% | -12.5% |
Beta (5 Year) | 0.55 | 0.65 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Dong-A St is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Frontier economic markets.
12345
Financial Models for Dong-A St
Model Gallery
Hide this widget
| 10Y DCF EBITDA ExitView Updated 11 hours ago |
| 10Y DCF Revenue ExitView Updated 11 hours ago |
| 10Y DCF Growth ExitView Updated 11 hours ago |
| 5Y DCF EBITDA ExitView Updated 11 hours ago |
| 5Y DCF Revenue ExitView Updated 11 hours ago |
| 5Y DCF Growth ExitView Updated 11 hours ago |
| DDM Multi StageView Updated 11 hours ago |
| DuPont ROE AnalysisView Updated 4 days ago |
| Earnings Power ValueView Updated 11 hours ago |
| 10Y Historical FinancialsView Updated 4 days ago |
| 5Y Historical FinancialsView Updated 4 days ago |
| EV / EBIT MultiplesView Updated 11 hours ago |
| EV / EBITDA MultiplesView Updated 11 hours ago |
| P/E MultiplesView Updated 11 hours ago |
| Price / Book MultiplesView Updated 11 hours ago |
| Price / Sales MultiplesView Updated 11 hours ago |
| EV / Revenue MultiplesView Updated 11 hours ago |
| CAPM WACC ModelView Updated 1 day ago |
| DDM Stable GrowthView Updated 11 hours ago |
Historical Financials
Full Financials
Hide this widget
| (KRW in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 635,393 | 663,980 | 697,869 | 181,062 | 178,622 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | 38,043 | 37,522 | 4,136 | 3,180 | 290 |
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 312,180 | 406,705 | 495,663 | 406,705 | 495,663 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (11,293) | (23,659) | (33,002) | (8,935) | (26,313) |
Analyst Notes
April 3, 2025
Hide this widget